Shares of OptiBiotix Health Plc (LON:OPTI – Get Free Report) passed below its fifty day moving average during trading on Thursday. The stock has a fifty day moving average of GBX 5.83 and traded as low as GBX 5.65. OptiBiotix Health shares last traded at GBX 5.80, with a volume of 231 shares traded.
OptiBiotix Health Trading Up 2.7%
The company has a market cap of £5.99 million, a PE ratio of -1.38 and a beta of 1.82. The firm’s fifty day moving average is GBX 5.83 and its 200 day moving average is GBX 5.76.
OptiBiotix Health (LON:OPTI – Get Free Report) last released its quarterly earnings results on Thursday, September 17th. The company reported GBX (1.52) earnings per share for the quarter. OptiBiotix Health had a negative return on equity of 77.85% and a negative net margin of 332.69%.
About OptiBiotix Health
OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome – the collective genome of the microbes in the body – in order to prevent and manage human disease and promote wellness.
OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.
OptiBiotix is also developing its own range of consumer supplements and health products.
Read More
- Five stocks we like better than OptiBiotix Health
- Is Texas Instruments Setting Up for Its Next Big Breakout?
- Pegasystems’ Q3 Miss Exposed the Problem Standing Between AI and Cash Flow
- Lam Research’s Earnings Beat Wasn’t the Real Story—Its 2027 Outlook Was
- Tesla’s Flying-Car Hype Hits an Earnings Reality Check
Receive News & Ratings for OptiBiotix Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptiBiotix Health and related companies with MarketBeat.com's FREE daily email newsletter.
